Multicentre Phase III Erythropoietic Protoporphyria Study

Clinical trial NCT04053270 · COMPLETED

Trial details

NCT number: NCT04053270
Sponsor: Clinuvel Pharmaceuticals Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Erythropoietic Protoporphyria

Start date: 2007-05-01
Primary completion: 2009-12-09
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.